Okitask (Ketoprofen)

Ketoprofen, the active ingredient in Okitask, is a non‑steroidal anti‑inflammatory drug presented as a 50 mg tablet for oral use. It is employed to relieve pain and inflammation in adults with musculoskeletal conditions. GNH USA supplies Okitask as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Okitask as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoprofen is an NSAID that reduces inflammation and pain in several musculoskeletal and inflammatory conditions.

- Rheumatoid arthritis: helps reduce joint pain, swelling and stiffness. - Osteoarthritis: alleviates chronic joint discomfort and improves mobility. - Acute musculoskeletal injury: provides short‑term relief of pain and inflammation following sprains, strains or bruises. - Post‑operative pain: used as part of multimodal analgesia after surgical procedures. - Dysmenorrhea: lessens menstrual‑related pelvic pain.

Ketoprofen may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia and abdominal pain. - Headache. - Dizziness. - Skin rash. - Mild elevation of liver enzymes.

Serious or Rare Side Effects: - Peptic ulcer disease or gastrointestinal bleeding. - Severe skin reactions such like Stevens‑Johnson syndrome. - Renal impairment or acute kidney injury. - Anaphylaxis or hypersensitivity reactions. - Hepatotoxic or liver failure. - Cardiovascular events such as thrombotic thrombosis.

Ketoprofen should be used cautiously when:

- Assess t  t  t ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...  ...  ... …  -  ... ... ... ... ... ... ... ... ... ... ...... ...  ... ... ... ... ... ... ... ... ... ... ... -  ... ... ....... ... ... ...  - ...  -  ...

...